PARP1 and cancer: Abnormally high ERK activity was generally thought to be associated with cancer cell survival and progression [28], but the recent study of Ibrahim et al. showed the interesting result that PI3K inhibition impaired BRCA1/2 expression via elevated ERK and sensitized BRCA-proficient TNBC to PARP inhibition [15].